Article
Mapping chromatin remodelling in glioblastoma identifies epigenetic regulation of key molecular pathways and novel druggable targets
6 Feb 2025
Abstract excerpt
BACKGROUND: Glioblastoma is the most common and aggressive malignant brain tumour in the adult population and its prognosis is dismal. The heterogeneous nature of the tumour, to which epigenetic dysregulation significantly contributes, is among the main therapeutic challenges of the disease. RESULTS: We have leveraged SYNGN, an experimental pipeline enabling the syngeneic comparison of glioblastoma stem cells and...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.
